Evidence map›Paper›PMID 40794018›Full record

ArticleMolecular carcinogenesis2025

Improved Methods for the Stable Generation of Human Papillomavirus-Driven Head and Neck Cancer Cell Lines.

Phuong N Le, Stephen B Keysar, Bettina Miller, J Jason Morton, Tugs-Saikhan Chimed, Nathaniel Alzofon, Cera Nieto, Kurtis D Davies, Carissa M Thomas, Alice N Weaver and 1 more

Abstract read
In one paragraph

Article in Molecular carcinogenesis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Phuong N LeDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Aurora, Colorado, USA.
Stephen B KeysarDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Aurora, Colorado, USA.
Bettina MillerDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Aurora, Colorado, USA.
J Jason MortonDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Aurora, Colorado, USA.
Tugs-Saikhan ChimedDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Aurora, Colorado, USA.
Nathaniel AlzofonDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Aurora, Colorado, USA.
Cera NietoDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Aurora, Colorado, USA.
Kurtis D DaviesDepartment of Pathology, UCSOM, Aurora, Colorado, USA.
Carissa M ThomasDepartment of Otolaryngology, UCSOM, Aurora, Colorado, USA.
Alice N WeaverDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Aurora, Colorado, USA.ORCID 0000-0002-9398-1471
Antonio JimenoDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine (UCSOM), Aurora, Colorado, USA.

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Treating recurrent HNSCC with radiation and dual TGF-Beta/PD-L1.P50CA261605 · NCI · UNIVERSITY OF COLORADO DENVER · PI JIMENO, ANTONIO, WANG, XIAO-JING · 2021 to 2025
$10.1M
NCI NIH HHS P30 CA046934NCI NIH HHS P50 CA261605This study was supported by P50CA261605 (Colorado head and neck cancer SPORE), P30-CA046934 (University of Colorado Cancer Center Support Grant), Ruth L. Kirschstein National Research Service Award T32CA17468 (P.N.L. trainee), the Daniel and Janet Mordecai Foundation (A.J.), and the Ronald and Carol Moore Family Foundation (A.J.).
6 · The paper itself

Abstract

Cell lines are an essential tool in research, leading to new discoveries involving drug studies, prognosis, treatment outcomes, genomic abnormalities, and cellular pathway deviations. There is an ongoing need for new cell lines in cancer research. Cell lines are often initiated by using tissue explants or dissociating cells onto plastic; this proves ineffective with challenging cell lines. Here we report two improved protocols in establishing stable cell lines. The first takes the more classical approach but is paired with fluorescence-activated cell sorting (FACs). The second protocol involves coculturing with feeder cells, coupled with FACs. We demonstrate the use of these protocols in the establishment of 17 cell lines, including several cancer associated fibroblasts (CAFs) and a human papilloma virus (HPV)- positive HNSCC cell line.

Indexed as

Cell Culture TechniquesHead and Neck NeoplasmsPapillomaviridaePapillomavirus InfectionsCancer-Associated FibroblastsCell Line, TumorCoculture TechniquesFlow CytometryHuman Papillomavirus VirusesHumansSquamous Cell Carcinoma of Head and Neckcell culturecell linefeeder cells

Identifiers

PMID40794018
PMCPMC13336141

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.